ADIposity and Bone Metabolism: Effects of eXercise-induced Weight Loss in Obese Adolescents (ADIBOX)

July 28, 2016 updated by: University Hospital, Clermont-Ferrand

The present protocol is mainly involved in the understanding of the local interaction between the released products by fat tissue and hormones production of bone tissue. These complex interactions between adipocyte and osteocyte activities could explain the mechanisms of the body responses to the strategies of weight loss that include diet and/or physical activity program, as well as the side effects encountered by these interventions.

Adolescence is a period of development characterized by many metabolic and somatic changes that may influence weight. Weights bearing physical activities are a key factor allowing body composition changes (i.e. fat and bone tissue). The difficulties of managing weight and the onset of overweight and obesity during this very important growth spurt lead to various hormonal dysregulation. The specific mechanisms of the evolution and interactions between these two parameters (fat and bone tissue) are not yet elucidated; therefore our aim is to analyze the possible connections between fat tissue and the quality of the skeleton in order to reduce related risks of the consequence of weight loss in obese individuals.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

The complex consequences of childhood obesity represent major concerns in most developed countries, largely contributing to metabolic complications with costly repercussions for the burden of disease. The burden is exemplified by high prevalence rates of overweight or obesity.

The ADIBOX protocol was designed to provide a better understanding of the bone-adipocyte cross-talk in adolescents with obesity and the effects of physical activity-induced weight loss on this cross-talk.

Obesity effectively leads to hormonal alterations favoring the accumulation of fat mass and loss of bone mass. Advancing the knowledge of the complex interactions between adipocyte and osteocyte activities may contribute to the mechanistic understanding of the body's responses to weight loss during adolescence and prevent cardiovascular risk. Indeed, the adipose-bone tissue cross-talk has been recently linked with cardiovascular diseases. Similarly as adipose tissue, released-products from bone tissue may act directly or indirectly on cardiovascular risk and diseases.

The ADIBOX study, a 40 weeks longitudinal study (LS) with repeated measures on four occasions (baseline and every fourteen weeks), will allow us to understand the effects of physical activity-induced weight loss on this cross-talk in obese adolescents.

Data will be analyzed using Stata (StataCorp, College Station, USA) and IBM Statistics SPSS version 22 (IBM Corp, 2013, Chicago, IL, USA) and significance will be accepted at a two-sided alpha level of p<0.05. After testing for normal distribution (Shapiro-Wilk test), data will be treated either by parametric or non-parametric analyses according to statistical assumptions.

Student t tests or Mann-Whitney U test will be performed to compare adipose tissue (total, subcutaneous, visceral) variation reported to bone mass variation at lumbar spine between groups at baseline. Pearson (or Spearman when appropriate) correlation coefficient will be used and compared with Fisher test (command corcor Stata) to measure the link between exercise-inducing weight loss on adipose tissue and bone mass variations. Longitudinal data will be treated using a mixed model analyses in order to treat fixed effects group, time and group x time interaction taking into account between and within participant variability.

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clermont-Ferrand, France, 63003
        • Recruiting
        • CHU Clermont-Ferrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 16 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All adolescent girls will have to be free of any recent history of hospitalization (past two years) or of systemic illness lasting more than two weeks in the past 12 months. .

Exclusion Criteria:

  • pregnant girl
  • diabetes
  • insulin-resistance
  • hypo or hyper-thyroid
  • consuming alcohol
  • smokers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: intervention group
an intervention group who will undergo the management program combining physical activity and restrictive diet at Tza Nou Medical House for 10 months
Other: a control group
a control group who will not undergo any intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
change from baseline fat mass measured by Dual energy X-ray Absorptiometry (DXA)
Time Frame: at 10 months.
at 10 months.
change from baseline bone mass measured by Dual energy X-ray Absorptiometry (DXA)
Time Frame: at 10 months
at 10 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Whole body measured by Dual energy X-ray Absorptiometry (DXA)
Time Frame: at 10 months
at 10 months
weight waist
Time Frame: at 10 months.
at 10 months.
waist circumference
Time Frame: at 10 months.
at 10 months.
lower limb bone lengths
Time Frame: at 10 months.
at 10 months.
Physical activity measured with International Physical Activity Questionnaire
Time Frame: at 10 months.
at 10 months.
Tanner's stages model for pubertal maturation
Time Frame: at 10 months.
at 10 months.
Energy metabolism assessed by cycle-ergometer submaximal aerobic fitness
Time Frame: at 10 months.
at 10 months.
bone mineral density measured by Peripheral Quantitative Computed Tomography
Time Frame: at 10 months.
at 10 months.
bone mineral status measured by Quantitative Ultra-Sound (QUS) on the non-dominant calcaneus.
Time Frame: at 10 months.
at 10 months.
Endocrine assays
Time Frame: at 10 months.
at 10 months.
Adolescents' observance to the weight loss lifestyle program
Time Frame: at 10 months
at 10 months
Metabolomics analysis in blood plasma
Time Frame: at 10 months
at 10 months
Ex-vivo mechanistic analysis
Time Frame: at 10 months
at 10 months
left ventricular end diastolic diameter measured by echocardiography
Time Frame: at 10 months
at 10 months
left ventricular end systolic diameter measured by echocardiography
Time Frame: at 10 months
at 10 months
posterior wall thickness measured by echocardiography
Time Frame: at 10 months
at 10 months
interventricular septum thickness measured by echocardiography
Time Frame: at 10 months
at 10 months
left ventricular mass indexed measured by echocardiography
Time Frame: at 10 months
at 10 months
left ventricular ejection fraction measured by echocardiography
Time Frame: at 10 months
at 10 months
valves velocity measured by echocardiography
Time Frame: at 10 months
at 10 months
isovolumic relaxation time measured by echocardiography
Time Frame: at 10 months
at 10 months
strain rate measured by echocardiography
Time Frame: at 10 months
at 10 months
myocardial dyssynchrony measured by echocardiography
Time Frame: at 10 months
at 10 months
carotid-intima-media thickness measured by echography
Time Frame: at 10 months
at 10 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (Anticipated)

October 1, 2016

Study Completion (Anticipated)

October 1, 2016

Study Registration Dates

First Submitted

November 3, 2015

First Submitted That Met QC Criteria

December 7, 2015

First Posted (Estimate)

December 10, 2015

Study Record Updates

Last Update Posted (Estimate)

July 29, 2016

Last Update Submitted That Met QC Criteria

July 28, 2016

Last Verified

July 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CHU-0249
  • 2015-A01024-45 (Registry Identifier: 2015-A01024-45)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on weight loss

Subscribe